Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$45.44 - $74.26 $17,176 - $28,070
-378 Reduced 7.11%
4,942 $324,000
Q4 2022

Feb 14, 2023

SELL
$41.39 - $81.0 $182,240 - $356,643
-4,403 Reduced 45.28%
5,320 $239,000
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $11,867 - $18,548
164 Added 1.72%
9,723 $704,000
Q2 2022

Aug 15, 2022

SELL
$87.2 - $114.05 $83,799 - $109,602
-961 Reduced 9.13%
9,559 $1.03 Million
Q1 2022

May 16, 2022

BUY
$94.19 - $124.49 $231,801 - $306,369
2,461 Added 30.54%
10,520 $1.17 Million
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $177,800 - $206,797
1,487 Added 22.63%
8,059 $1.03 Million
Q3 2021

Nov 15, 2021

SELL
$109.17 - $142.35 $8,842 - $11,530
-81 Reduced 1.22%
6,572 $875,000
Q2 2021

Aug 16, 2021

SELL
$100.34 - $115.69 $5,318 - $6,131
-53 Reduced 0.79%
6,653 $719,000
Q1 2021

May 17, 2021

BUY
$101.51 - $125.27 $264,738 - $326,704
2,608 Added 63.64%
6,706 $706,000
Q4 2020

Feb 16, 2021

BUY
$85.88 - $105.36 $67,415 - $82,707
785 Added 23.69%
4,098 $426,000
Q3 2020

Nov 16, 2020

BUY
$72.74 - $92.5 $6,764 - $8,602
93 Added 2.89%
3,313 $284,000
Q2 2020

Aug 14, 2020

BUY
$48.02 - $79.04 $154,624 - $254,508
3,220 New
3,220 $236,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.